Answers are grounded in this paper and cite their sources.
This personal view provides a perspective on achieving equitable and sustainable implementation of precision oncology programs in Latin America and the Caribbean region. Developed as part of the Lancet Oncology Commission on Cancer Genomics and Precision Oncology, this analysis aims to summarise the current challenges that health systems in the region face in implementing precision oncology programs and translating molecular testing into clinical practice and public health benefits, highlighting the interdependence of science and policy. We propose a roadmap for the implementation of precision oncology in Latin America and the Caribbean, based on region-specific policy frameworks and the best available scientific evidence, to align regulation, priority-setting, financing, access, and local capacity. We conclude that the successful integration of precision oncology into routine oncology practice will depend on aligning regulatory clarity, economic evaluation, equitable access strategies, and regional capacity building, all guided by scientific evidence.
No takes yet. Share an insight, caveat, or question.
Gutiérrez-Babativa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: